Study of the factor of ascites fluid of Erlich tumor
Belokhvostov, A.S.; Zelenkova, N.K.; Kalinovskiĭ, V.P.; Mikhalevskaia, L.A.; Perevozchikov, A.P.
Voprosy Onkologii 22(10): 66-72
1976
ISSN/ISBN: 0507-3758 PMID: 1014496 Document Number: 105416
The factor of nucleic nature was isolated by phenol method from acellular ascitic fluid of Ehrlich tumor. DNA was found to be the main component of the factor concerned as indicated by chemical analysis after its purification with preparative electrophoresis in 2.5% polyacrylamid gel or centrifugation in CsCl gradient. Moreover, the factor can be destroyed in incubation with DNA-s. It is not improbable that this factor consists also of small amounts of RNA.
Document emailed within 1 workday
Related Documents
Ghinelli, C.; Pons, M.L.; Terzano, G. 1975: Cytologic changes in Erlich ascites tumor treated with antiblastic drugs and hyperbaric oxygen Acta Cytologica 19(1): 43-44Terlikowski, S.ła.; Sulkowska, M.; Nowak, H.F. 2002: The effect of recombinant human tumor necrosis factor-alpha on Ehrlich ascites tumor growth Journal of Environmental Pathology Toxicology and Oncology: Official Organ of the International Society for Environmental Toxicology and Cancer 21(1): 87-92
Riazantseva, I.N.; Beliaeva, M.I.; Vinter, V.G. 1972: DNAase activity in tumorous growth and the action on it of the RNA from Ehrlich tumor ascites fluid Voprosy Onkologii 18(9): 33-37
Nolan, R.D.; Grasmuk, H.; Drews, J. 1974: Properties of elongation factor 1 from ascites tumor cells Acta Biologica et Medica Germanica 33(5-6): 919-927
Matsak, N.I.; Romanov, I.A.; Antokhin, A.I. 1983: Comparative study of the action of an inhibitor and a stimulator present in Ehrlich ascites tumor cells on cell proliferation in the tumor Biulleten' Eksperimental'noi Biologii i Meditsiny 96(12): 74-76
Sartori, M.; Andorno, S.; Bermani, G.; Colombi, S.; Gambaro, M.; La Terra, G.; Leone, F.; Molinari, G.L.; Aglietta, M. 1996: Diagnosis of neoplastic ascites: combined use of albumin gradient between serum and ascites and cholesterol in ascitic fluid Recenti Progressi in Medicina 87(2): 75-77
Katano, M.; Yamamoto, H.; Hisatsugu, T. 1986: Management of malignant ascites with a streptococcal preparation, OK-432: induction of growth inhibition factor(s) against tumor cells Nihon Geka Gakkai Zasshi 87(4): 471
El-Asfahani, A.M.; Mizuno, D.; Hashimoto, Y.; Ishidate, M.; Nishioka, K. 1975: A tumor-specific cytotoxic and neutralizing factor in rats immunized with ascites hepatoma induced by azo dyes Gan 66(1): 11-19
Villert, A.B.; Kolomiets, L.A.; Kondakova, I.V.; Spirina, L.V.; Yunusova, N.V. 2016: Proteins of insuline-like growth factor system in tumor and ascites in ovarian cancer: the relation with neoajuvant chemotherapy effectiveness Voprosy Onkologii 62(6): 788-793
Merkle, P. 1984: The oncologic emergency. Surgical therapy of ascites, including tumor ascites Münchener Medizinische Wochenschrift 126(9): 239-240
Bandyopadhyay, R.; Bandyopadhyay, S.Kumar.; Ghosal, J.; Kumar, U.; Dutta, A. 2006: Study of biochemical parameters of ascitic fluid in exudative ascites with special reference to tuberculous peritonitis Journal of the Indian Medical Association 104(4): 174 176-177 185
Kopper, L.; Lapis, K.; Institóris, L. 1976: Incorporation of 3H-dibromodulcitol and 3H-dianhydrodulcitol into ascites tumor cells. Autoradiographic study Neoplasma 23(1): 47-52
Rossomando, E.F.; White, L.B.; Hadjimichael, J.; Shafer, D. 1992: Immunomagnetic separation of tumor necrosis factor alpha. I. Batch procedure for human temporomandibular fluid Journal of Chromatography 583(1): 11-18
Suzuki, Y.; Chen, L.P.; Liu, C.M.; Morita, T.; Wheelock, E.F. 1989: Immune regulation of the L5178Y murine tumor-dormant state: induction of cell- and soluble factor-mediated inhibition of tumor cell growth by tumor necrosis factor and gamma-interferon Cancer Research 49(8): 2028-2033
Lu, M.; Zheng, F.; Huang, H.N. 1987: Morphometric study on sensitization by hematoporphyrin derivative in Ehrlich ascites tumor cells irradiated by gamma-ray Zhonghua Zhong Liu Za Zhi 9(5): 325-327; 19
Kawaguchi, T.; Endo, M.; Tobai, S.; Nakamura, K. 1979: Behavior pattern of rat ascites tumor cells arrested in liver sinusoids: an electron microscopic study Gan 70(3): 277-290
Alsalameh, S.; Mattka, B.; Al-Ward, R.; Lorenz, H.M.; Manger, B.; Pfizenmaier, K.; Grell, M.; Kalden, J.R. 1999: Preferential expression of tumor necrosis factor receptor 55 (TNF-R55) on human articular chondrocytes: selective transcriptional upregulation of TNF-R75 by proinflammatory cytokines interleukin 1beta, tumor necrosis factor-alpha, and basis fibroblast growth factor Journal of Rheumatology 26(3): 645-653
Broudy, V.C.; Harlan, J.M.; Adamson, J.W. 1987: Disparate effects of tumor necrosis factor-alpha/cachectin and tumor necrosis factor-beta/lymphotoxin on hematopoietic growth factor production and neutrophil adhesion molecule expression by cultured human endothelial cells Journal of Immunology 138(12): 4298-4302
Duchini, A.; Govindarajan, S.; Santucci, M.; Zampi, G.; Hofman, F.M. 1996: Effects of tumor necrosis factor-alpha and interleukin-6 on fluid-phase permeability and ammonia diffusion in CNS-derived endothelial cells Journal of Investigative Medicine: the Official Publication of the American Federation for Clinical Research 44(8): 474-482
Hawkins, D.L.; Cargile, J.L.; MacKay, R.J.; Broome, T.A.; Skelley, L.A. 1995: Effect of tumor necrosis factor antibody on synovial fluid cytokine activities in equine antebrachiocarpal joints injected with endotoxin American Journal of Veterinary Research 56(10): 1292-1299